263 related articles for article (PubMed ID: 7654518)
21. Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes.
Anlauf M; Schäfer MK; Eiden L; Weihe E
J Comp Neurol; 2003 Apr; 459(1):90-111. PubMed ID: 12629668
[TBL] [Abstract][Full Text] [Related]
22. The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei.
Nirenberg MJ; Liu Y; Peter D; Edwards RH; Pickel VM
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8773-7. PubMed ID: 7568015
[TBL] [Abstract][Full Text] [Related]
23. The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors.
Duerr JS; Frisby DL; Gaskin J; Duke A; Asermely K; Huddleston D; Eiden LE; Rand JB
J Neurosci; 1999 Jan; 19(1):72-84. PubMed ID: 9870940
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase A affects trafficking of the vesicular monoamine transporters in PC12 cells.
Yao J; Erickson JD; Hersh LB
Traffic; 2004 Dec; 5(12):1006-16. PubMed ID: 15522101
[TBL] [Abstract][Full Text] [Related]
25. Identification of residues involved in substrate recognition by a vesicular monoamine transporter.
Merickel A; Rosandich P; Peter D; Edwards RH
J Biol Chem; 1995 Oct; 270(43):25798-804. PubMed ID: 7592763
[TBL] [Abstract][Full Text] [Related]
26. Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2.
Finn JP; Edwards RH
J Biol Chem; 1997 Jun; 272(26):16301-7. PubMed ID: 9195934
[TBL] [Abstract][Full Text] [Related]
27. Expression of a bovine vesicular monoamine transporter in COS cells.
Gasnier B; Krejci E; Botton D; Massoulié J; Henry JP
FEBS Lett; 1994 Apr; 342(3):225-9. PubMed ID: 8150075
[TBL] [Abstract][Full Text] [Related]
28. The vesicular monoamine transporter 2 (VMAT2) is expressed by normal and tumor cutaneous mast cells and Langerhans cells of the skin but is absent from Langerhans cell histiocytosis.
Anlauf M; Schafer MK; Depboylu C; Hartschuh W; Eiden LE; Kloppel G; Weihe E
J Histochem Cytochem; 2004 Jun; 52(6):779-88. PubMed ID: 15150286
[TBL] [Abstract][Full Text] [Related]
29. An acidic motif retains vesicular monoamine transporter 2 on large dense core vesicles.
Waites CL; Mehta A; Tan PK; Thomas G; Edwards RH; Krantz DE
J Cell Biol; 2001 Mar; 152(6):1159-68. PubMed ID: 11257117
[TBL] [Abstract][Full Text] [Related]
30. Lithium ions modulate the expression of VMAT2 in rat brain.
Cordeiro ML; Gundersen CB; Umbach JA
Brain Res; 2002 Oct; 953(1-2):189-94. PubMed ID: 12384252
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional activation of vesicular monoamine transporter 2 in the pre-B cell line Ea3.123.
Watson F; Deavall DG; Macro JA; Kiernan R; Dimaline R
Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):193-9. PubMed ID: 9882615
[TBL] [Abstract][Full Text] [Related]
32. Transient developmental expression of monoamine transporters in the rodent forebrain.
Lebrand C; Cases O; Wehrlé R; Blakely RD; Edwards RH; Gaspar P
J Comp Neurol; 1998 Nov; 401(4):506-24. PubMed ID: 9826275
[TBL] [Abstract][Full Text] [Related]
33. Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.
Temple W; Mendelsohn L; Kim GE; Nekritz E; Gustafson WC; Lin L; Giacomini K; Naranjo A; Van Ryn C; Yanik GA; Kreissman SG; Hogarty M; Matthay KK; DuBois SG
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):474-481. PubMed ID: 26338179
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
Staal RG; Sonsalla PK
J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
[TBL] [Abstract][Full Text] [Related]
35. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action.
Fon EA; Pothos EN; Sun BC; Killeen N; Sulzer D; Edwards RH
Neuron; 1997 Dec; 19(6):1271-83. PubMed ID: 9427250
[TBL] [Abstract][Full Text] [Related]
36. Transport of histamine by vesicular monoamine transporter-2.
Merickel A; Edwards RH
Neuropharmacology; 1995 Nov; 34(11):1543-7. PubMed ID: 8606801
[TBL] [Abstract][Full Text] [Related]
37. Norepinephrine transporter expression in cholinergic sympathetic neurons: differential regulation of membrane and vesicular transporters.
Habecker BA; Klein MG; Cox BC; Packard BA
Dev Biol; 2000 Apr; 220(1):85-96. PubMed ID: 10720433
[TBL] [Abstract][Full Text] [Related]
38. Vesicular monoamine transporter 2 as a marker of gastric enterochromaffin-like cell tumors.
Rindi G; Paolotti D; Fiocca R; Wiedenmann B; Henry JP; Solcia E
Virchows Arch; 2000 Mar; 436(3):217-23. PubMed ID: 10782879
[TBL] [Abstract][Full Text] [Related]
39. Functional identification and molecular cloning of a human brain vesicle monoamine transporter.
Erickson JD; Eiden LE
J Neurochem; 1993 Dec; 61(6):2314-7. PubMed ID: 8245983
[TBL] [Abstract][Full Text] [Related]
40. The vesicular monoamine transporter: from chromaffin granule to brain.
Henry JP; Sagné C; Bedet C; Gasnier B
Neurochem Int; 1998 Mar; 32(3):227-46. PubMed ID: 9587917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
